Abbott Laboratories

Abbott Laboratories ABT Stock

$108.52   1.184150%
Add to favorites
Exchange
Market Cap
$187.95B
LOW - HIGH [24H]
$107.03 - $109.28
VOLUME [24H]
$6.18M
P/E Ratio
40.49
Earnings per share
$2.68
ISIN
US0028241000
Price   Prediction

Abbott Laboratories Price Chart

Sorry, that's all we've gotfor now...

Abbott Laboratories (ABT) stock price today is 108.52 USD on NYSE (+1.18% on the day). Updated .

Abbott Laboratories ABT Financial and Trading Overview

Abbott Laboratories stock price 108.52 USD
Previous Close 107.25 USD
Open 108.2 USD
Bid 108.6 USD x 10000
Ask 108.6 USD x 10000
Day's Range 107.03 - 109.28 USD
52 Week Range 81.97 - 132.03 USD
Volume 6.18M USD
Avg. Volume 8.95M USD
Market Cap 187.95B USD
Beta (5Y Monthly) 0.537
PE Ratio (TTM) 40.044277
EPS (TTM) 2.68 USD
Forward Dividend & Yield 2.52 (2.35%)
Ex-Dividend Date October 15, 2026
1y Target Est 118.91 USD

ABT Valuation Measures

Enterprise Value 215.69B USD
Trailing P/E 40.044277
Forward P/E 18.278683
PEG Ratio (5 yr expected) 1.54
Price/Sales (ttm) 3.8970392
Price/Book (mrq) 3.6833887
Enterprise Value/Revenue 4.472
Enterprise Value/EBITDA 18.824

Trading Information

Abbott Laboratories Stock Price History

Beta (5Y Monthly) 0.537
52-Week Change -16.90%
S&P500 52-Week Change 12.28%
52 Week High 132.03 USD
52 Week Low 81.97 USD
50-Day Moving Average 103.91 USD
200-Day Moving Average 101.56 USD

ABT Share Statistics

Avg. Volume (3 month) 8.95M USD
Avg. Daily Volume (10-Days) 8.78M USD
Shares Outstanding 1.73B
Float 1.72B
Short Ratio 1.95
% Held by Insiders 0.49%
% Held by Institutions 83.96%
Shares Short 19.06M
Short % of Float 1.23%
Short % of Shares Outstanding 1.09%

Dividends & Splits

Trailing Annual Dividend Rate 2.52
Trailing Annual Dividend Yield 2.34%
5 Year Average Dividend Yield 186.00%
Payout Ratio 0.9254
Last Split Factor 10000:4798

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 9.74%
Operating Margin (ttm) 15.64%
Gross Margin 57.17%
EBITDA Margin 23.75%

Management Effectiveness

Return on Assets (ttm) 4.90%
Return on Equity (ttm) 9.13%

Income Statement

Revenue (ttm) 48.23B USD
Revenue Per Share (ttm) 27.73 USD
Quarterly Revenue Growth (yoy) 14.49%
Gross Profit (ttm) 27.57B USD
EBITDA 11.46B USD
Net Income Avi to Common (ttm) 4.68B USD
Diluted EPS (ttm) 2.71
Quarterly Earnings Growth (yoy) -44.00000000000000000000000000000000%

Balance Sheet

Total Cash (mrq) 4.3B USD
Total Cash Per Share (mrq) 2.48 USD
Total Debt (mrq) 31.44B USD
Total Debt/Equity (mrq) 60.9 USD
Current Ratio (mrq) 1.455
Book Value Per Share (mrq) 29.462

Cash Flow Statement

Operating Cash Flow (ttm) 8.86B USD
Levered Free Cash Flow (ttm) 6.07B USD

Profile of Abbott Laboratories

Country United States
State IL
City Abbott Park
Address 100 Abbott Park Road
ZIP 60064-6400
Phone 224 667 6100
Website https://www.abbott.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 122000

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Q&A For Abbott Laboratories Stock

What is a current ABT stock price?

Abbott Laboratories ABT stock price today per share is 108.52 USD.

How to purchase Abbott Laboratories stock?

You can buy ABT shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Abbott Laboratories?

The stock symbol or ticker of Abbott Laboratories is ABT.

Which industry does the Abbott Laboratories company belong to?

The Abbott Laboratories industry is Medical Devices.

How many shares does Abbott Laboratories have in circulation?

The max supply of Abbott Laboratories shares is 1.73B.

What is Abbott Laboratories Price to Earnings Ratio (PE Ratio)?

Abbott Laboratories PE Ratio is 40.49253500 now.

What was Abbott Laboratories earnings per share over the trailing 12 months (TTM)?

Abbott Laboratories EPS is 2.68 USD over the trailing 12 months.

Which sector does the Abbott Laboratories company belong to?

The Abbott Laboratories sector is Healthcare.

Abbott Laboratories ABT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us S&P 500 INDEX SPX US 7561.67 USD —
-0.4
2.75B USD — — — — — — 2.75B USD —
us S&P 500 (Yahoo.com) GSPC US 7561.67 USD —
-0.4
2.73B USD — 7499.4 USD — 7621.78 USD — — 2.73B USD —
us S&P 100 SP100 US 3720.62 USD —
-0.5
1.43B USD — 3689.79 USD — 3753.79 USD — — 1.43B USD —
us Better Investing 100 BIXX US 245.36 USD —
0
— — — — — — — — —
us US Tech OMX CRD Global Sustainab QCRD US 1595.1 USD —
0
— — — — — — — — —
us US Tech US Price Setters Index NQPRCE US 3232.77 USD —
+0.24
— — 3217.58 USD — 3242.35 USD — — — —
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
— — 2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD — — —
us The Capital Strength Net Total NQCAPSTN US 4603.39 USD —
+0.53
— — 4575.17 USD — 4604.99 USD — — — —
us US Tech US Low Volatility Divide LVDA US 1422.47 USD —
+0.74
— — 1414.58 USD — 1423.8 USD — — — —
us NYSE Arca Pharmaceutical Index DRG US 1398.81 USD —
+0.73
— — — — — — — — —
us US Tech US Broad Dividend Achiev DAA US 4809.52 USD —
+0.13
— — 4776.66 USD — 4818.82 USD — — — —
us NYSE Composite Index NYA US 24520.82 USD —
+0.22
— — — — — — — — —
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 3748.08 USD —
-0.7
— — 3701.51 USD — 3782.39 USD — — — —
us US Tech CRD Global Sustainabilit NQCRD US 1735.62 USD —
0
— — 1715.94 USD — 1757.95 USD — — — —
us The Capital Strength Index NQCAPST US 3837.28 USD —
+0.51
— — 3813.75 USD — 3838.61 USD — — — —
us US Tech US Broad Dividend Achiev DAATR US 9078.62 USD —
+0.14
— — 9016.62 USD — 9096.18 USD — — — —
$2.19T
Total marketcap
$70.53B
Total volume
BTC 59.34%   •   ETH 10.13%
Dominance
Select currency